Neumora logomark
Skip to main content

Patients

We are grateful to the patients who have

chosen to participate in our previous

and ongoing clinical studies  

Patient participation in clinical research contributes valuable information that allows our scientists to better understand the safety and effectiveness of our investigational medicines.

Before a new therapy can be made available to the general public, multiple studies involving healthy volunteers and patient volunteers must be conducted to evaluate the safety and effectiveness of the therapy. These may involve a new treatment (also referred to as a clinical trial) or could be an observational study. Potential new medicines need to be extensively evaluated in multiple clinical trials to understand their safety and effectiveness. In the United States, these studies are regulated by the Food and Drug Agency (FDA), and in other countries, by similar regulatory bodies.

Neumora logomark

We are currently active, but no longer recruiting patients for the following clinical study:

Study in Major Depressive Disorder With NMRA (BTRX)-335140 vs Placebo

Learn More

Our Pipeline

Neumora has a broad pipeline of novel medicines for neuropsychiatric disorders and neurodegenerative disorders, each of which will be paired with a proprietary Precision Phenotype™ to ensure a targeted approach to development.

In addition to internally discovered programs, Neumora has partnered with Amgen to pursue additional complementary opportunities and maximize the value we can deliver to patients.

Pipeline